GlaxoSmithKline Gets Expanded FDA Win for Fluarix

By January 11, 2018 BioPharma No Comments

Glaxo announced today it has received approval from the FDA’s Center for Biologics Evaluation and Research expanding the indication for FLUARIX to include use in persons 6 months and older.
Source: BioSpace